Dr. Jeffrey R. Jay, M.D. »

Palisade Bio shares owned by Dr. Jeffrey R. Jay, M.D.

Quarter-by-quarter ownership of Palisade Bio (PALI) shares owned by Dr. Jeffrey R. Jay, M.D. from 13F filings

Historical chart of Dr. Jeffrey R. Jay, M.D. investment in Palisade Bio

Tip: Access up to 7 years of quarterly data

All positions including Palisade Bio held by Dr. Jeffrey R. Jay, M.D. consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Palisade Bio by Dr. Jeffrey R. Jay, M.D.

Quarter filed Position value Share count Share price at filing
2026-03-31 $6.0M 3.4M 1.75

More positions owned by Dr. Jeffrey R. Jay, M.D.

Apogee Therapeutics (APGE)
Vor Biopharma Com New (VOR)
Zura Bio Class A Ord Shs (ZURA)
Amylyx Pharmaceuticals (AMLX)
Immunitybio Put Option (IBRX)
Nektar Therapeutics Com New (NKTR)
Sol-gel Technologies Shs New (SLGL)
Alumis (ALMS)
Bright Minds Biosciences Com New (DRUG)
Annexon (ANNX)
Kalvista Pharmaceuticals (KALV)
Immunovant (IMVT)
Jade Biosciences Com New (JBIO)
Contineum Therapeutics Cl A (CTNM)
Zenas Biopharma (ZBIO)

View all positions for Dr. Jeffrey R. Jay, M.D.

Top funds holding Palisade Bio

Henderson Group
Octagon Capital Advisors
Perceptive Advisors
Ameriprise Financial
Commodore Capital
RA Capital Management
Franklin Resources
Eversept Partners
Goldman Sachs Group
Boxer Capital Management
Morgan Stanley
Adage Capital Partners GP
Dr. Jeffrey R. Jay, M.D.
Balyasny Asset Management
Federated Investors

View all funds holding Palisade Bio